About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The work of our group is mainly focused on personalized medicine, including chemical-functional stability studies of drugs in individualized preparations to be administered both orally and parenterally, as well as parenteral nutrition; research focused on the evaluation and/or design of population pharmacokinetic/pharmacodynamic (PK/PD) models and the characterization of the pharmacokinetics of certain drugs of therapeutic interest in the general population or in certain population groups; and research focused on pharmacogenetics and pharmacogenomics. Our research is also focused on advanced interventions: drug evaluation studies (effectiveness, safety and economic studies); and mobile health and telepharmacy.
PMID: 37748560 Journal: PHARMACOLOGICAL RESEARCH Year: 2023 Reference: Pharmacol Res. 2023 Sep 23:106938. doi: 10.1016/j.phrs.2023.106938. Impact factor: Publication type: Letter or abstract Authors: Balboa, Maria Jesus; Bossacoma, Ferran; Clemente, Susana; Clemente, Susana; Fernandez-Lorenzo, Ana; Fobelo, Maria Jose; Garcia-Romero, Ruth; Lopez-Fernandez, Luis A; Loverdos, Ines; Magallares, Lorena et al. DOI: 10.1016/j.phrs.2023.106938
PMID: 37754495 Journal: Current Oncology Year: 2023 Reference: Curr Oncol. 2023 Aug 30;30(9):7984-8004. doi: 10.3390/curroncol30090580. Impact factor: Publication type: Paper in international publication Authors: Carles, Joan; Carles, Joan; Carreras, Maria-Josep; Carreras, Maria-Josep; Farriols, Anna; Farriols, Anna; Felip, Enriqueta; Felip, Enriqueta; Gorgas, Maria-Queralt; Gorgas, Maria-Queralt et al. DOI: 10.3390/curroncol30090580
PMID: 37073757 Journal: Nutricion Hospitalaria Year: 2023 Reference: Nutr Hosp. 2023 Apr 11. doi: 10.20960/nh.04436. Impact factor: Publication type: Paper in international publication Authors: Albertos, Raquel; Barquin, Raquel; Berlana, David; Cea, Cristina; Lopez-Hellin, Juan; Montoro-Ronsano, J Bruno; Pau-Parra, Alba; Zabalegui, Alba et al. DOI: 10.20960/nh.04436
PMID: 37850411 Journal: JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY Year: 2023 Reference: J Investig Allergol Clin Immunol. 2023 Oct 18:0. doi: 10.18176/jiaci.0941. Impact factor: Publication type: Paper in international publication Authors: Aladro, Yolanda; Alvarez-Lafuente, Roberto; Arroyo, Rafael; Casanova-Peno, Ignacio; Comabella, Manuel; Costa-Frossard, Lucienne; Cruz, M J; Dominguez-Mozo, Maria Inmaculada; Espejo, D; Garcia-Dominguez, Jose Manuel et al. DOI: 10.18176/jiaci.0941
PMID: 35404224 Journal: Journal of Clinical Sleep Medicine Year: 2022 Reference: J Clin Sleep Med. 2022 Jul 1;18(7):1857-1864. doi: 10.5664/jcsm.10016. Impact factor: 4.062 Publication type: Paper in international publication Authors: Sampol, Julia, Saez, Maria, Marti, Sergi, Pallero, Mercedes, Barrecheguren, Miriam, Ferrer, Jaume, Sampol, Gabriel, Vimes Fortis, Alba, Guillen Del Castillo, Alfredo, et al. DOI: 10.5664/jcsm.10016
PMID: 35379101 Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia H Year: 2022 Reference: Farm Hosp. 2022 Jan 27;46(2):88-95. Impact factor: 0 Publication type: Paper in international publication Authors: Poveda-Andres, Jose Luis, Ruiz-Caldes, Maria Jose, Carrera-Soler, Maria Jose, Clopes-Estela, Ana, Flores-Moreno, Sandra, Garcia-Pellicer, Javier, Giraldez-Quiroga, Miriam, Lopez-Briz, Eduardo, Lozano-Blazquez, Ana, Megias-Vericat, Juan Eduardo et al. DOI: 10.7399/fh.13036
Within the framework of a clinical trial, the first 3D printed medicine in Europe in the pediatric field will be tested.
